» Articles » PMID: 36694048

Chlorpromazine, an Inverse Agonist of D1R-Like, Differentially Targets Voltage-Gated Calcium Channel (Ca) Subtypes in MPFC Neurons

Overview
Journal Mol Neurobiol
Date 2023 Jan 24
PMID 36694048
Authors
Affiliations
Soon will be listed here.
Abstract

The dopamine receptor type 1 (D1R) and the dopamine receptor type 5 (D5R), which are often grouped as D1R-like due to their sequence and signaling similarities, exhibit high levels of constitutive activity. The molecular basis for this agonist-independent activation has been well characterized through biochemical and mutagenesis in vitro studies. In this regard, it was reported that many antipsychotic drugs act as inverse agonists of D1R-like constitutive activity. On the other hand, D1R is highly expressed in the medial prefrontal cortex (mPFC), a brain area with important functions such as working memory. Here, we studied the impact of D1R-like constitutive activity and chlorpromazine (CPZ), an antipsychotic drug and D1R-like inverse agonist, on various neuronal Ca conductances, and we explored its effect on calcium-dependent neuronal functions in the mouse medial mPFC. Using ex vivo brain slices containing the mPFC and transfected HEK293T cells, we found that CPZ reduces Ca2.2 currents by occluding D1R-like constitutive activity, in agreement with a mechanism previously reported by our lab, whereas CPZ directly inhibits Ca1 currents in a D1R-like activity independent manner. In contrast, CPZ and D1R constitutive activity did not affect Ca2.1, Ca2.3, or Ca3 currents. Finally, we found that CPZ reduces excitatory postsynaptic responses in mPFC neurons. Our results contribute to understanding CPZ molecular targets in neurons and describe a novel physiological consequence of CPZ non-canonical action as a D1R-like inverse agonist in the mouse brain.

Citing Articles

Nano-organization of synaptic calcium signaling.

McCarthy C, Kavalali E Biochem Soc Trans. 2024; 52(3):1459-1471.

PMID: 38752834 PMC: 11346461. DOI: 10.1042/BST20231385.


Canonical and Non-Canonical Antipsychotics' Dopamine-Related Mechanisms of Present and Next Generation Molecules: A Systematic Review on Translational Highlights for Treatment Response and Treatment-Resistant Schizophrenia.

de Bartolomeis A, Ciccarelli M, De Simone G, Mazza B, Barone A, Vellucci L Int J Mol Sci. 2023; 24(6).

PMID: 36983018 PMC: 10051989. DOI: 10.3390/ijms24065945.

References
1.
Cools R . Role of dopamine in the motivational and cognitive control of behavior. Neuroscientist. 2008; 14(4):381-95. DOI: 10.1177/1073858408317009. View

2.
Leal E, Fernandez-Duran B, Agulleiro M, Conde-Siera M, Miguez J, Cerda-Reverter J . Effects of dopaminergic system activation on feeding behavior and growth performance of the sea bass (Dicentrarchus labrax): a self-feeding approach. Horm Behav. 2013; 64(1):113-21. DOI: 10.1016/j.yhbeh.2013.05.008. View

3.
Beaulieu J, Espinoza S, Gainetdinov R . Dopamine receptors - IUPHAR Review 13. Br J Pharmacol. 2015; 172(1):1-23. PMC: 4280963. DOI: 10.1111/bph.12906. View

4.
Abi-Dargham A, Mawlawi O, Lombardo I, Gil R, Martinez D, Huang Y . Prefrontal dopamine D1 receptors and working memory in schizophrenia. J Neurosci. 2002; 22(9):3708-19. PMC: 6758376. DOI: 20026302. View

5.
Tiberi M, Caron M . High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype. J Biol Chem. 1994; 269(45):27925-31. View